| Andrew Wikaryasz, C-AA | |
|
3000 Arlington Ave, Toledo, OH 43614-2595 | |
| (419) 383-3556 | |
| (419) 383-3550 |
| Full Name | Andrew Wikaryasz |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 5 Years |
| Location | 3000 Arlington Ave, Toledo, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972066546 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | (* (Not Available)) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Toledo Medical Center | Toledo, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Toledo Physicians Llc | 8729983416 | 315 |
News Archive
Experts at an American Society of Tropical Medicine and Hygiene meeting this week said that resistance to the best available drug to treat malaria "is more widespread in Southeast Asia than previously reported," Science News/Wired Science reports. Researchers have been monitoring drug resistance along the Thailand-Cambodia border where patients taking artemisinin combination therapy - the most potent treatment for malaria - have been clearing the parasite from their bodies more slowly.
A patient with advanced bladder cancer experienced a complete response for 14 months to the drug combination everolimus and pazopanib in a phase I trial, and genomic profiling of his tumor revealed two alterations that may have caused this exceptional response, according to a study published in Cancer Discovery, a journal of the American Association for Cancer Research.
The Cardiovascular Research Foundation (CRF) of New York, NY and the Uppsala Clinical Research Center (UCR) of Uppsala, Sweden announced today the initiation of the PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) II trial and the PROSPECT ABSORB sub study.
The three Clinical and Translational Science Award (CTSA) institutions in Ohio — Case Western Reserve University, University of Cincinnati and The Ohio State University — and their partnering institutions have established a statewide collaborative agreement allowing a single organization's Institutional Review Board (IRB) to assume IRB responsibilities on behalf of multiple institutions when conducting multicenter studies.
› Verified 4 days ago
| Entity Name | University Of Toledo Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942296033 PECOS PAC ID: 8729983416 Enrollment ID: O20031205000019 |
News Archive
Experts at an American Society of Tropical Medicine and Hygiene meeting this week said that resistance to the best available drug to treat malaria "is more widespread in Southeast Asia than previously reported," Science News/Wired Science reports. Researchers have been monitoring drug resistance along the Thailand-Cambodia border where patients taking artemisinin combination therapy - the most potent treatment for malaria - have been clearing the parasite from their bodies more slowly.
A patient with advanced bladder cancer experienced a complete response for 14 months to the drug combination everolimus and pazopanib in a phase I trial, and genomic profiling of his tumor revealed two alterations that may have caused this exceptional response, according to a study published in Cancer Discovery, a journal of the American Association for Cancer Research.
The Cardiovascular Research Foundation (CRF) of New York, NY and the Uppsala Clinical Research Center (UCR) of Uppsala, Sweden announced today the initiation of the PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) II trial and the PROSPECT ABSORB sub study.
The three Clinical and Translational Science Award (CTSA) institutions in Ohio — Case Western Reserve University, University of Cincinnati and The Ohio State University — and their partnering institutions have established a statewide collaborative agreement allowing a single organization's Institutional Review Board (IRB) to assume IRB responsibilities on behalf of multiple institutions when conducting multicenter studies.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Wikaryasz, C-AA 3355 Glendale Ave Fl 3, Toledo, OH 43614-2426 Ph: (419) 383-3556 | Andrew Wikaryasz, C-AA 3000 Arlington Ave, Toledo, OH 43614-2595 Ph: (419) 383-3556 |
News Archive
Experts at an American Society of Tropical Medicine and Hygiene meeting this week said that resistance to the best available drug to treat malaria "is more widespread in Southeast Asia than previously reported," Science News/Wired Science reports. Researchers have been monitoring drug resistance along the Thailand-Cambodia border where patients taking artemisinin combination therapy - the most potent treatment for malaria - have been clearing the parasite from their bodies more slowly.
A patient with advanced bladder cancer experienced a complete response for 14 months to the drug combination everolimus and pazopanib in a phase I trial, and genomic profiling of his tumor revealed two alterations that may have caused this exceptional response, according to a study published in Cancer Discovery, a journal of the American Association for Cancer Research.
The Cardiovascular Research Foundation (CRF) of New York, NY and the Uppsala Clinical Research Center (UCR) of Uppsala, Sweden announced today the initiation of the PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) II trial and the PROSPECT ABSORB sub study.
The three Clinical and Translational Science Award (CTSA) institutions in Ohio — Case Western Reserve University, University of Cincinnati and The Ohio State University — and their partnering institutions have established a statewide collaborative agreement allowing a single organization's Institutional Review Board (IRB) to assume IRB responsibilities on behalf of multiple institutions when conducting multicenter studies.
› Verified 4 days ago
Joshua Lynn Jay, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 3000 Arlington Ave, Toledo, OH 43614 Phone: 419-383-3556 | |
Kera Sparks, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 4235 Secor Rd, Toledo, OH 43623 Phone: 419-473-3561 | |
Andrew Mccray, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 3000 Arlington Ave, Toledo, OH 43614 Phone: 419-383-4000 | |
Brienne N Seekford, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 3000 Arlington Ave, Toledo, OH 43614 Phone: 419-383-3888 Fax: 419-383-2860 | |
Jonathan Daniel Cox, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 3000 Arlington Ave, Mailstop #1137, Toledo, OH 43614 Phone: 419-383-3556 Fax: 419-383-3550 | |
Mr. Jacob Kanjuparamban, A.A. Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 3000 Arlington Ave, Toledo, OH 43614 Phone: 419-383-3556 Fax: 419-383-3550 | |
Mr. Patrick Bolger, A.A. Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 3000 Arlington Ave, Toledo, OH 43614 Phone: 419-383-3556 Fax: 419-353-3550 |